Vitamin K antagonists (warfarins) Vitamin K antagonists, such as warfarin, remain a 1st-line treatment option for patients with VTE, with the exception of selected patients, including pregnant women, who should continue to take heparin, and patients with cancer-associated VTE, who should receive a LMWH (emerging evidence indicates that edoxaban or rivaroxaban also are alternatives).